The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion-Mediated Cytotoxicity.
about
NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.Current status of poly(ADP-ribose) polymerase inhibitors and future directions.Wild-type and mutated IDH1/2 enzymes and therapy responses.Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates.Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
P2860
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion-Mediated Cytotoxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@en
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@nl
type
label
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@en
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@nl
prefLabel
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@en
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@nl
P2093
P2860
P1433
P1476
The Alkylating Chemotherapeuti ...... pletion-Mediated Cytotoxicity.
@en
P2093
A John Iafrate
Andrew S Chi
David E Fisher
Fumi Higuchi
Ganesh M Shankar
Hiroaki Wakimoto
Julie J Miller
Kensuke Tateishi
Mara V A Koerner
Nina Lelic
P2860
P304
P356
10.1158/0008-5472.CAN-16-2263
P407
P577
2017-06-16T00:00:00Z